SCHOTT Pharma AG & Co. KGaA, DE000A3ENQ51

SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

15.01.2024 - 18:59:59 | dgap.de

SCHOTT Pharma AG & Co. KGaA / DE000A3ENQ51

EQS Preliminary announcement financial reports: SCHOTT Pharma AG & Co. KGaA / Preliminary announcement on the disclosure of financial statements
SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

15.01.2024 / 18:59 CET/CEST
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


SCHOTT Pharma AG & Co. KGaA hereby announces that the following financial reports shall be disclosed:

Report Type: Annual financial report

Language: German
Date of disclosure: January 26, 2024
Address: https://www.schott-pharma.com/investor-relations/de/news-und-veroeffentlichungen/berichte-und-praesentationen/

Language: English
Date of disclosure: January 26, 2024
Address: https://www.schott-pharma.com/investor-relations/news-publications/reports-and-presentations/

Report Type: Annual financial report of the group

Language: German
Date of disclosure: January 26, 2024
Address: https://www.schott-pharma.com/investor-relations/de/news-und-veroeffentlichungen/berichte-und-praesentationen/

Language: English
Date of disclosure: January 26, 2024
Address: https://www.schott-pharma.com/investor-relations/news-publications/reports-and-presentations/

Report Type: Financial report of the group (half-year/Q2)

Language: German
Date of disclosure: June 27, 2024
Address: https://www.schott-pharma.com/investor-relations/de/news-und-veroeffentlichungen/berichte-und-praesentationen/

Language: English
Date of disclosure: June 27, 2024
Address: https://www.schott-pharma.com/investor-relations/news-publications/reports-and-presentations/


15.01.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

Language: English
Company: SCHOTT Pharma AG & Co. KGaA
Hattenbergstraße 10
55122 Mainz
Germany

 
End of News EQS News Service

1815447  15.01.2024 CET/CEST fncls.ssp?fn=show_t_gif&application_id=1815447&application_name=news&site_id=trading-house

Hol dir jetzt den Wissensvorsprung der Aktien-Profis.

 <b>Hol dir jetzt den Wissensvorsprung der Aktien-Profis.</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Aktien-Empfehlungen - Dreimal die Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
DE000A3ENQ51 | SCHOTT PHARMA AG & CO. KGAA | boerse | 64593822 |